Hyppää sisältöön
    • Suomeksi
    • In English
Trepo
  • Suomeksi
  • In English
  • Kirjaudu
Näytä viite 
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

Serum insulin-like growth factor 1 in young children with moderate acute malnutrition: secondary analysis of a randomized trial in Burkina Faso

Helt, Thora W.; Cichon, Bernardette; Fabiansen, Christian; Iuel-Brockdorff, Ann Sophie; Yaméogo, Charles W.; Ritz, Christian; Briend, André; Michaelsen, Kim F.; Filteau, Suzanne; Friis, Henrik; Christensen, Vibeke B.; Grenov, Benedikte (2025)

 
Avaa tiedosto
serum-insulin-like-growth-factor-1-in-young-children-with-moderate-acute-malnutrition-secondary-analysis-of-a-randomised-trial-in-burkina-faso-1.pdf (529.5Kt)
Lataukset: 



Helt, Thora W.
Cichon, Bernardette
Fabiansen, Christian
Iuel-Brockdorff, Ann Sophie
Yaméogo, Charles W.
Ritz, Christian
Briend, André
Michaelsen, Kim F.
Filteau, Suzanne
Friis, Henrik
Christensen, Vibeke B.
Grenov, Benedikte
2025

British Journal of Nutrition
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
doi:10.1017/S0007114525000212
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202506056773

Kuvaus

Peer reviewed
Tiivistelmä
Insulin-like growth factor 1 (IGF-1) is an important growth factor in childhood. We aimed to investigate the impact of food supplements for treatment of moderate acute malnutrition (MAM) on serum IGF-1 (sIGF-1). Secondary analysis of a randomized 2×2×3 factorial nutrition trial was performed. Children aged 6-23 months with MAM received 2093 kJ/day as lipid-based nutrient supplement (LNS) or corn-soy blend (CSB), containing either dehulled soy or soy isolate and different quantities of dried skimmed milk (0%, 20% or 50% of total protein) for 12 weeks. The trial was double-blind with regard to soy and milk, but not to matrix (LNS vs. CSB). sIGF-1 was measured at inclusion and after 12 weeks supplementation. Of 1609 children enrolled, 1455 (90%) had sIGF-1 measured at both time points. During supplementation sIGF-1 increased 6.7 (95%CI 6.1; 7.3) ng/ml compared with an expected age-dependent decrease of 0.3 (95%CI 0.2; 0.4) ng/ml. Children who received LNS vs. CSB had lower increase in sIGF-1 (-8%, 95%CI -12; -3). The effect of LNS was partly attenuated when sIGF-1 was corrected for inflammation. Children who received soy isolate compared with dehulled soy had higher increase in sIGF-1 (6%, 95%CI 1; 12). Milk content did not affect sIGF-1. Overall, sIGF-1 increased during supplementation. The lower increase with LNS vs. CSB was only partly explained by increased inflammation with LNS, and needs further investigation. Isolate vs. dehulled soy led to a higher increase which may be due to antinutrients in dehulled soy.
Kokoelmat
  • TUNICRIS-julkaisut [24199]
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste
 

 

Selaa kokoelmaa

TekijätNimekkeetTiedekunta (2019 -)Tiedekunta (- 2018)Tutkinto-ohjelmat ja opintosuunnatAvainsanatJulkaisuajatKokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste